Innovation
10 patent families (9 granted) — focus: Human necessities; filing pace active.
| Year | Filings |
|---|---|
| 2024 | 2 |
| 2025 | 8 |
Investor mix
1 investor on record; lead investors include Co-win Ventures.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 100% |
Developer of a technology for transdermal drug delivery device
10 patent families (9 granted) — focus: Human necessities; filing pace active.
| Year | Filings |
|---|---|
| 2024 | 2 |
| 2025 | 8 |
1 investor on record; lead investors include Co-win Ventures.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 100% |